ANTHRA PHARMACEUTICALS, INC.
103 Carnegie Center, Suite 102
Princeton, NJ 08540
(609) 514-1060
June 23, 1998
VIA EDGAR
Division of Corporate Finance
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Filing Desk
Re: Anthra Pharmaceuticals, Inc. Registration Statement on Form 8-A
File Number 000-24107
Request for Withdrawal
Ladies and Gentlemen:
Anthra Pharmaceuticals, Inc., a Delaware corporation (the
"Registrant"), hereby makes application to immediately withdraw its Registration
Statement on Form 8-A (the "8-A Registration Statement"), relating to the
Registrant's Common Stock, $0.01 par value per share. This request for
withdrawal of the 8-A Registration Statement is being made because the
Registrant will not request effectiveness for its Registration Statement on Form
S-1 (Registration No. 333-47725) by the date the 8-A Registration Statement
would automatically become effective pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
Should you have any questions regarding this matter, please
call our attorney, John R. Hempill of Morrison & Foerster LLP, at (212)
468-8082.
Sincerely,
ANTRHA PHARMACEUTICALS, INC.
By: /s/ Michael C. Walker
Michael C. Walker
President
cc: Shelley E. Parratt
(Securities and Exchange Commission)
Joseph K. Pascale
(Securities and Exchange Commission)
Eric C. Wasiuta
(NASDAQ National Stock Market, Inc.)
